Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05045079 · ClinicalTrials.gov registry record · NA
Rhythm Control and Potential Early Surgery for Tricuspid Regurgitation
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05045079: Completed NA study, sponsored by Mayo Clinic.
NCT05045079 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05045079, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the clinical impact of non-surgical and surgical treatment in atrial fibrillation induced tricuspid regurgitation (AFTR).
Interventions
- PROCEDURE Inferior Vena Caval (IVC) Occlusion maneuver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2023-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05045079
The ClinicalTrials.gov registry entry for NCT05045079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inferior Vena Caval (IVC) Occlusion maneuver is the first listed.
NCT05045079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05045079 about?
NCT05045079 is a clinical study titled "Rhythm Control and Potential Early Surgery for Tricuspid Regurgitation". The purpose of this study is to understand the clinical impact of non-surgical and surgical treatment in atrial fibrillation induced tricuspid regurgitation (AFTR).
What is the current status of trial NCT05045079?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2022-01-20. Estimated completion is 2023-08-09.
What interventions are being tested in trial NCT05045079?
The interventions under investigation include: Inferior Vena Caval (IVC) Occlusion maneuver (PROCEDURE).
Who is sponsoring clinical trial NCT05045079?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.